Might FTC Amgen Lawsuit Have Ripple Impact?
This text has been revised and up to date from the unique model. A Federal Commerce Fee lawsuit in search of a preliminary injunction to dam biopharmaceutical big Thousand Oaks-based Amgen Inc. from buying a smaller Irish pharmaceutical firm is using a decades-old antitrust enforcement concept that has observers questioning whether or not biotech and biopharma corporations … [Read more…]